Affinity DataEC50: 5.51E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 1.13E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 140nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: >3.00E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 650nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 200nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 160nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 710nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 620nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 520nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: <5.00E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 77nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 68nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 200nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 50nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 2.30E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 140nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 77nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 3.00E+3nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 650nMAssay Description:Agonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 1.30E+3nMAssay Description:Antagonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 1.30E+3nMAssay Description:Antagonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 470nMAssay Description:Antagonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 2.05E+3nMAssay Description:Antagonist activity at Rev-Erb alpha (unknown origin) by BMAL1-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 3.00E+4nMAssay Description:Antagonist activity at Rev-Erb alpha (unknown origin) by RORE-luciferase reporter assayMore data for this Ligand-Target Pair
Affinity DataEC50: 150nMAssay Description:Inverse agonist activity at Rev-Erb alpha LBD (unknown origin) by FRET assayMore data for this Ligand-Target Pair
Affinity DataEC50: 20nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 20nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 160nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 1.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 2.90E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 70nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 990nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 120nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 80nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 330nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 50nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 580nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 70nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 610nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 950nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 1.30E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 930nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 370nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 790nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: 890nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair












































